PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Gheorghiade, Mihai
TI  - Emerging Therapies for HF Target Different Pathophysiology
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 29--30
VI  - 14
IP  - 12
4099  - http://mdc.sagepub.com/content/14/12/29.short
4100  - http://mdc.sagepub.com/content/14/12/29.full
AB  - Several new agents are being explored for the management of heart failure (HF), which target different pathways involved in this complex disease. This article discusses human stresscopin, as well as a review of neurohumoral modulation, potential advantages of biased ligand at the angiotensin II type 1 receptor, soluble guanylate cyclase (sGC) stimulators, and potassium-binding polymers in HF.